BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3585142)

  • 21. [Swine alveolar macrophages: description and functional analysis].
    Charley B
    Ann Rech Vet; 1982; 13(1):1-9. PubMed ID: 6819804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function.
    Hunninghake GW; Fauci AS
    J Immunol; 1977 Jan; 118(1):146-50. PubMed ID: 830745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of surfactant on mouse alveolar macrophage cytotoxicity].
    Takahashi N; Masutani M; Horie T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):859-66. PubMed ID: 8366624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW
    Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing.
    Martin JH; Edwards SW
    J Immunol; 1993 Apr; 150(8 Pt 1):3478-86. PubMed ID: 8385686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophages.
    Hengst JC; Kan-Mitchell J; Kempf RA; Strumpf IJ; Sharma OP; Kortes VL; Mitchell MS
    Cancer Res; 1985 Jan; 45(1):459-63. PubMed ID: 3871173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage-induced enhancement of endogenous tumor lysosome activity.
    Urban JL
    Cancer Res; 1981 Jun; 41(6):2221-9. PubMed ID: 7237422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lidocaine inhibits macrophage mediated cytotoxicity and enhances neutrophil mediated cytotoxicity.
    Cameron DJ
    Jpn J Exp Med; 1986 Dec; 56(6):265-9. PubMed ID: 3599491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.
    Cameron DJ; Churchill WH
    J Clin Invest; 1979 May; 63(5):977-84. PubMed ID: 447836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
    Bourassa B; Monaghan S; Rittling SR
    Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
    Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte-mediated antibody-dependent cell-mediated cytotoxicity and spontaneous cytotoxicity in normals and cancer patients as assayed by human erythrocyte lysis.
    Bernhard MI; Pace RC; Unger SW; Wanebo HJ
    Cancer Res; 1983 Sep; 43(9):4504-10. PubMed ID: 6871879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
    Bordignon C; Avallone R; Peri G; Polentarutti N; Mangioni C; Mantovani A
    Clin Exp Immunol; 1980 Aug; 41(2):336-42. PubMed ID: 6160006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human lung lavage surfactant enhances staphylococcal phagocytosis by alveolar macrophages.
    O'Neill SJ; Lesperance E; Klass DJ
    Am Rev Respir Dis; 1984 Dec; 130(6):1177-9. PubMed ID: 6548882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromium and tritiated thymidine releases from target cells are differential events in human monocyte/macrophage-mediated cytotoxicity.
    Higashi N; Taki H; Nishimura Y; Higuchi M; Osawa T
    Cell Immunol; 1993 Sep; 150(2):333-42. PubMed ID: 8370076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and functional analysis of normal canine blood monocytes and resident alveolar macrophages.
    Shaw SE; Anderson NV
    Am J Vet Res; 1984 Jan; 45(1):87-90. PubMed ID: 6367562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.
    Gaynor CD; McCormack FX; Voelker DR; McGowan SE; Schlesinger LS
    J Immunol; 1995 Dec; 155(11):5343-51. PubMed ID: 7594549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC; Proud D; Schleimer RP; Plaut M
    J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.